Skip to main content
. 2021 May 27;16:58. doi: 10.1186/s13012-021-01127-x

Fig. 3.

Fig. 3

Reach and implementation of the PVS-PREDIAPS clinical intervention for type 2 diabetes prevention by center and comparison group. Note: Columns represent the percentage of non-diabetic patients aged ≥ 30 years with a known cardiovascular risk factor and an impaired fasting glucose level (≥ 110-125 md/dl) exposed to A1: assessment of healthy lifestyles or A4: prescription of lifestyle change with a personalized plan